tiprankstipranks
Pacific Health Care Organization (PFHO)
OTHER OTC:PFHO
US Market
Want to see PFHO full AI Analyst Report?

Pacific Health Care Organization (PFHO) AI Stock Analysis

6 Followers

Top Page

PFHO

Pacific Health Care Organization

(OTC:PFHO)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
$1.00
▼(-23.66% Downside)
Action:DowngradedDate:05/02/26
The score is supported primarily by strong profitability, good cash conversion, and very conservative leverage. It is held back by weak technicals (price below major moving averages, negative MACD, and sub-40 RSI) and near-term fundamentals showing a modest TTM revenue decline and softer free cash flow growth, with valuation appearing roughly mid-range at a ~19.8 P/E.
Positive Factors
Profitability and margins
Sustained high gross and net margins indicate durable pricing power and efficient cost controls in PFHO's service model. Margins near 50%/20% provide a long-term earnings cushion against revenue volatility, support reinvestment in networks and technology, and underpin consistent return generation.
Negative Factors
Recent revenue decline
A TTM revenue decline signals potential demand softness, lost contracts, or timing issues in services volume. Over several quarters this can erode the scale advantages of PFHO's business, limit operating leverage, and make it harder to sustain margin expansion and long-term top-line driven growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability and margins
Sustained high gross and net margins indicate durable pricing power and efficient cost controls in PFHO's service model. Margins near 50%/20% provide a long-term earnings cushion against revenue volatility, support reinvestment in networks and technology, and underpin consistent return generation.
Read all positive factors

Pacific Health Care Organization (PFHO) vs. SPDR S&P 500 ETF (SPY)

Pacific Health Care Organization Business Overview & Revenue Model

Company Description
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third-party administrators, municipalities, and other industries in t...
How the Company Makes Money
The company generates revenue by providing specialized health care management solutions to its clients. Its key revenue streams include fees charged for professional services such as medical cost containment, case management, and utilization revie...

Pacific Health Care Organization Financial Statement Overview

Summary
Profitability is solid with strong TTM margins (gross ~50%, net ~20%) and good cash conversion (FCF ~98% of net income) alongside essentially zero debt. Offsetting this are a modest TTM revenue decline (-4.8%), softer TTM free cash flow growth (-8.3%), and an apparent inconsistency in the latest balance sheet asset level that reduces confidence in the most recent balance-sheet comparability.
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
71
Positive
BreakdownTTMDec 2025Dec 2024Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.39M6.72M6.07M5.63M5.74M5.40M
Gross Profit3.20M3.22M2.58M2.16M2.18M2.01M
EBITDA1.57M1.03M1.30M716.06K700.12K1.25M
Net Income1.29M1.39M883.58K767.93K492.89K995.02K
Balance Sheet
Total Assets71.67K13.48M12.43M11.82M12.05M11.33M
Cash, Cash Equivalents and Short-Term Investments2.40M12.21M11.10M10.44M10.78M10.09M
Total Debt0.000.0035.30K56.49K50.14K70.37K
Total Liabilities496.53K401.85K745.60K1.02M735.07K508.46K
Stockholders Equity13.27M13.07M11.69M10.80M11.32M10.82M
Cash Flow
Free Cash Flow1.03M1.14M665.95K914.84K672.37K368.01K
Operating Cash Flow1.06M1.16M675.08K932.36K711.24K386.39K
Investing Cash Flow-981.64K-990.15K-1.13M806.79K-8.76M-18.38K
Financing Cash Flow-37.00K-72.31K35.30K-1.21M0.00218.90K

Pacific Health Care Organization Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.31
Price Trends
50DMA
1.23
Negative
100DMA
1.22
Negative
200DMA
1.16
Negative
Market Momentum
MACD
-0.02
Positive
RSI
26.05
Positive
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PFHO, the sentiment is Negative. The current price of 1.31 is above the 20-day moving average (MA) of 1.18, above the 50-day MA of 1.23, and above the 200-day MA of 1.16, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 26.05 is Positive, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PFHO.

Pacific Health Care Organization Risk Analysis

Pacific Health Care Organization disclosed 24 risk factors in its most recent earnings report. Pacific Health Care Organization reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Pacific Health Care Organization Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$5.97B1.26-39.45%27.50%-1091.30%
66
Neutral
$3.75B79.2411.50%41.81%
65
Neutral
$27.32B2.61-28.72%17.02%-294.77%
64
Neutral
$14.08M19.8311.75%-0.98%31.63%
56
Neutral
$1.41B8.41-25.73%40.40%-89.29%
54
Neutral
$10.29B121.404.44%7.72%-83.64%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PFHO
Pacific Health Care Organization
1.10
0.37
50.27%
CNC
Centene
55.33
-7.59
-12.06%
MOH
Molina Healthcare
197.44
-129.58
-39.62%
CLOV
Clover Health Investments
2.68
-1.09
-28.91%
OSCR
Oscar Health
19.84
2.82
16.57%
ALHC
Alignment Healthcare
18.14
2.62
16.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 02, 2026